EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis

Sahla El Mahdaoui, Marie Mathilde Hansen, Malene Bredahl Hansen, Victoria Hyslop Hvalkof, Helle Bach Søndergaard, Mie Reith Mahler, Jeppe Romme Christensen, Finn Sellebjerg, Marina Rode von Essen

Clinical Immunology · 2024

DOI: 10.1016/j.clim.2024.110262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Sahla El Mahdaoui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark. Electronic address: sa…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Antigens, CD20, T Follicular Helper Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicular helper T (Tfh) cells and their interplay with B cells likely contribute to the pathogenesis of relapsing-remitting multiple sclerosis (RRMS). Tfh cells are enriched in cerebrospinal fluid (CSF) in RRMS, but effects of anti-CD20 therapy are unknown. We investigated Tfh cells in controls, untreated and anti-CD20-treated patients with RRMS using flow cytometry. CSF Tfh cells were increased in untreated patients. Compared to paired blood samples, CD25- Tfh cells were enriched in CSF in RRMS, but not in controls. Contrast-enhancing brain MRI lesions and IgG index correlated with CSF CD25- Tfh cell frequency in untreated patients with RRMS. Anti-CD20 therapy reduced the numbers of circulating PD1+ Tfh cells and CD25- Tfh cells, and the frequency of CSF CD25- Tfh cells. The study suggests that CD25- Tfh cells are recruited to the CSF in RRMS, associated with focal inflammation, and are reduced by anti-CD20 therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Sclerosis, Relapsing-RemittingAntigens, CD20T Follicular Helper CellsHumansFemaleAdultMaleMiddle AgedT-Lymphocytes, Helper-InducerRituximabT-Lymphocyte Subsets

Stichwörter der Autor:innen

B-cell depletionCD4CXCL13CXCR5OcrelizumabRituximab

Substanzen

Antigens, CD20Rituximab

Autor:innen und Institutionen

  • Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark. Electronic address: sahla.el.mahdaoui.01@regionh.dk.
  • Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
  • Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Zitieren

APA

El Mahdaoui, S., Hansen, M. M., Hansen, M. B., Hvalkof, V. H., Søndergaard, H. B., Mahler, M. R., Romme Christensen, J., Sellebjerg, F., & von Essen, M. R. (2024). Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110262

Vancouver

El Mahdaoui S, Hansen MM, Hansen MB, Hvalkof VH, Søndergaard HB, Mahler MR, et al. Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110262

BibTeX
@article{ElMahdaoui2024,
  author = {El Mahdaoui, Sahla and Hansen, Marie Mathilde and Hansen, Malene Bredahl and Hvalkof, Victoria Hyslop and Søndergaard, Helle Bach and Mahler, Mie Reith and Romme Christensen, Jeppe and Sellebjerg, Finn and von Essen, Marina Rode},
  title = {Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis},
  journal = {Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.clim.2024.110262}
}
Kostenlos starten →